Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials

G Querin, MG Biferi, PF Pradat - Journal of neuromuscular …, 2022 - content.iospress.com
The development of new possible treatments for C9orf72-related ALS and the possibility of
early identification of subjects genetically at risk of developing the disease is creating a …

Brain connectivity and network analysis in amyotrophic lateral sclerosis

V Renga - Neurology Research International, 2022 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no effective
treatment or cure. ALS is characterized by the death of lower motor neurons (LMNs) in the …

Amyotrophic lateral sclerosis–frontotemporal dementia: Shared and divergent neural correlates across the clinical spectrum

C Cividini, S Basaia, EG Spinelli, E Canu… - Neurology, 2022 - AAN Enterprises
Background and Objectives A significant overlap between amyotrophic lateral sclerosis
(ALS) and behavioral variant of frontotemporal dementia (bvFTD) has been observed at …

[HTML][HTML] C9orf72 ALS mutation carriers show extensive cortical and subcortical damage compared to matched wild-type ALS patients

A Nigri, M Umberto, M Stanziano, S Ferraro, D Fedeli… - NeuroImage: Clinical, 2023 - Elsevier
Objective C9orf72 mutation carriers with different neurological phenotypes show cortical and
subcortical atrophy in multiple different brain regions, even in pre-symptomatic phases …

Multiparametric microstructural MRI and machine learning classification yields high diagnostic accuracy in amyotrophic lateral sclerosis: proof of concept

TD Kocar, A Behler, AC Ludolph, HP Müller… - Frontiers in …, 2021 - frontiersin.org
The potential of multiparametric quantitative neuroimaging has been extensively discussed
as a diagnostic tool in amyotrophic lateral sclerosis (ALS). In the past, the integration of …

[HTML][HTML] Segmental alterations of the corpus callosum in motor neuron disease: A DTI and texture analysis in 575 patients

M Münch, HP Müller, A Behler, AC Ludolph… - NeuroImage: Clinical, 2022 - Elsevier
Introduction Within the core neuroimaging signature of amyotrophic lateral sclerosis (ALS),
the corpus callosum (CC) is increasingly recognized as a consistent feature. The aim of this …

Evaluation and categorisation of individual patients based on white matter profiles: Single-patient diffusion data interpretation in neurodegeneration

M Tahedl, A Murad, J Lope, O Hardiman… - Journal of the neurological …, 2021 - Elsevier
The majority of radiology studies in neurodegenerative conditions infer group-level imaging
traits from group comparisons. While this strategy is helpful to define phenotype-specific …

Longitudinal monitoring of amyotrophic lateral sclerosis by diffusion tensor imaging: Power calculations for group studies

A Behler, D Lulé, AC Ludolph, J Kassubek… - Frontiers in …, 2022 - frontiersin.org
Introduction Diffusion tensor imaging (DTI) can be used to map disease progression in
amyotrophic lateral sclerosis (ALS) and therefore is a promising candidate for a biomarker in …

The ipsilateral silent period: an early diagnostic marker of callosal disconnection in ALS

A Hübers, J Kassubek, HP Müller… - … in Chronic Disease, 2021 - journals.sagepub.com
Introduction: Imaging studies showed affection of the corpus callosum (CC) in amyotrophic
lateral sclerosis (ALS). Here, we sought to determine whether these structural alterations …

[HTML][HTML] Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal diffusion tensor imaging study

HP Müller, A Abrahao, C Beaulieu, M Benatar… - NeuroImage: Clinical, 2024 - Elsevier
Objective The corticospinal tract (CST) reveals progressive microstructural alterations in ALS
measurable by DTI. The aim of this study was to evaluate fractional anisotropy (FA) along …